C
AbbVie Inc. ABBV
$185.71 $1.690.92% NYSE
Recommendation
Prev Close
$184.02
Volume
5,216,727
Avg Vol (90D)
7,490,489
Market Cap
$325.05B
Dividend & Yield
$6.38(3.47%)
52-Week Range
$153.58 - $218.66
P/E (TTM)
78.40
EPS (TTM)
$2.35
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3 Biotech Giants Gaining From U.S. Sales and Policy Shifts
5/2/2025 - MarketBeat
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc. ...
5/19/2025 - GuruFocus
Top Biotech Stocks To Watch Today - May 18th
5/19/2025 - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc. (ABBV) Shareholders
5/19/2025 - Globe Newswire
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact The Gross Law Firm about pending Class Action - ABBV
5/19/2025 - PR Newswire
Waters Parkerson & CO. LLC Cuts Stake in AbbVie Inc. (NYSE:ABBV)
5/19/2025 - Ticker Report
The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
5/19/2025 - Zacks Investment Research
The Only 5 ETFs You Need to Build Wealth for Retirement
5/19/2025 - 24/7 Wall St.
PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?
5/19/2025 - Zacks Investment Research
Temasek Holdings Private Ltd Lowers Stock Position in AbbVie Inc. (NYSE:ABBV)
5/19/2025 - MarketBeat
Texas Bank & Trust Co Makes New Investment in AbbVie Inc. (NYSE:ABBV)
5/19/2025 - MarketBeat
1,620 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Trace Wealth Advisors LLC
5/19/2025 - MarketBeat
State of Wyoming Buys 6,612 Shares of AbbVie Inc. (NYSE:ABBV)
5/19/2025 - MarketBeat
Strategic Global Advisors LLC Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)
5/19/2025 - MarketBeat
Strategic Wealth Partners Ltd. Buys 4,343 Shares of AbbVie Inc. (NYSE:ABBV)
5/19/2025 - MarketBeat
Best Pharmaceutical Stocks To Add to Your Watchlist - May 17th
5/18/2025 - MarketBeat
Promising Biotech Stocks To Follow Today - May 17th
5/18/2025 - MarketBeat
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
5/18/2025 - Fool.com Headlines
State of Wyoming Buys 6,612 Shares of AbbVie Inc. (NYSE:ABBV)
5/18/2025 - Ticker Report
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Toronto Dominion Bank
5/18/2025 - MarketBeat
Strategic Global Advisors LLC Boosts Stock Holdings in AbbVie Inc. (NYSE:ABBV)
5/18/2025 - Ticker Report
Rep. Josh Gottheimer Buys AbbVie Inc. (NYSE:ABBV) Stock
5/18/2025 - Ticker Report
Top Pharmaceutical Stocks To Research - May 16th
5/17/2025 - MarketBeat
AbbVie (NYSE:ABBV) Trading Up 0.3% - Should You Buy?
5/17/2025 - MarketBeat
If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
4/25/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$57.37B
EBITDA (TTM)
$27.13B
EBIT (TTM)
$18.78B
Net Income (TTM)
$4.20B
Balance Sheet
Total Assets (Q)
$136.17B
Total Debt (Q)
$70.02B
Total Liabilities (Q)
$134.70B
Book Value Per Share (Q)
$0.8039
Cash Flow
Cash from Operations (TTM)
$16.40B
Cash from Investing (TTM)
-$11.97B
Cash from Financing (TTM)
-$17.29B
Net Change in Cash (TTM)
-$12.89B
Filings
Filing Date
Friday, May 9, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.16
7-Day Total Return
0.07%
30-Day Total Return
-0.67%
60-Day Total Return
-8.18%
90-Day Total Return
3.51%
Year to Date Total Return
3.56%
1-Year Total Return
12.01%
2-Year Total Return
31.87%
3-Year Total Return
22.39%
5-Year Total Return
126.45%
52-week Low
May 30, 2024 - $153.58
52-week High
Mar 10, 2025 - $218.66
Valuation
Market Cap
$325.05B - Mega Cap
Enterprise Value
$389.94B
Price/Sales (TTM)
5.68
Price/Book (Q)
228.91
Dividends and Shares
Shares Outstanding
1.77B
Dividend Per Share (Most Recent)
$1.64
Dividend Per Share (TTM)
$6.38
Corporate Info
Website
www.abbvie.com
Phone Number
847 932 7900
Address
1 North Waukegan Road
North Chicago, IL 60064-6400
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers... more
NYSE 05/19/2025 4:00PM Eastern Quotes delayed